Market Closed -
Bombay S.E.
03:30:53 10/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
383.8
INR
|
+1.29%
|
|
-4.19%
|
+4.99%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
686.5
|
608.9
|
567.4
|
638.7
|
775.5
|
1,944
|
Enterprise Value (EV)
1 |
403.4
|
331
|
330.2
|
423.2
|
566
|
1,751
|
P/E ratio
|
33.4
x
|
10.6
x
|
10.6
x
|
8.98
x
|
13.8
x
|
8.13
x
|
Yield
|
2.07%
|
4.08%
|
1.88%
|
2.78%
|
2.29%
|
1.28%
|
Capitalization / Revenue
|
0.7
x
|
0.54
x
|
0.43
x
|
0.44
x
|
0.49
x
|
0.95
x
|
EV / Revenue
|
0.41
x
|
0.3
x
|
0.25
x
|
0.29
x
|
0.35
x
|
0.85
x
|
EV / EBITDA
|
13.7
x
|
5.4
x
|
4.58
x
|
4.85
x
|
7.34
x
|
5.23
x
|
EV / FCF
|
3.01
x
|
57.8
x
|
295
x
|
-201
x
|
-11.4
x
|
154
x
|
FCF Yield
|
33.3%
|
1.73%
|
0.34%
|
-0.5%
|
-8.78%
|
0.65%
|
Price to Book
|
0.7
x
|
0.6
x
|
0.54
x
|
0.58
x
|
0.68
x
|
1.42
x
|
Nbr of stocks (in thousands)
|
7,092
|
7,092
|
7,092
|
7,092
|
7,092
|
7,092
|
Reference price
2 |
96.80
|
85.85
|
80.00
|
90.05
|
109.4
|
274.0
|
Announcement Date
|
29/08/18
|
22/08/19
|
28/08/20
|
30/08/21
|
26/08/22
|
31/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
977.5
|
1,120
|
1,319
|
1,439
|
1,598
|
2,052
|
EBITDA
1 |
29.54
|
61.34
|
72.17
|
87.34
|
77.13
|
334.6
|
EBIT
1 |
-2.807
|
27.98
|
37.76
|
50.81
|
41.13
|
296.2
|
Operating Margin
|
-0.29%
|
2.5%
|
2.86%
|
3.53%
|
2.57%
|
14.43%
|
Earnings before Tax (EBT)
1 |
26.95
|
56.81
|
64.07
|
92.79
|
73.44
|
320.7
|
Net income
1 |
22.56
|
57.55
|
53.56
|
71.1
|
56.11
|
239
|
Net margin
|
2.31%
|
5.14%
|
4.06%
|
4.94%
|
3.51%
|
11.65%
|
EPS
2 |
2.897
|
8.110
|
7.551
|
10.03
|
7.912
|
33.70
|
Free Cash Flow
1 |
134.2
|
5.723
|
1.121
|
-2.11
|
-49.68
|
11.37
|
FCF margin
|
13.72%
|
0.51%
|
0.08%
|
-0.15%
|
-3.11%
|
0.55%
|
FCF Conversion (EBITDA)
|
454.11%
|
9.33%
|
1.55%
|
-
|
-
|
3.4%
|
FCF Conversion (Net income)
|
594.6%
|
9.95%
|
2.09%
|
-
|
-
|
4.76%
|
Dividend per Share
2 |
2.000
|
3.500
|
1.500
|
2.500
|
2.500
|
3.500
|
Announcement Date
|
29/08/18
|
22/08/19
|
28/08/20
|
30/08/21
|
26/08/22
|
31/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
283
|
278
|
237
|
215
|
210
|
193
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
134
|
5.72
|
1.12
|
-2.11
|
-49.7
|
11.4
|
ROE (net income / shareholders' equity)
|
2.03%
|
5.73%
|
5.19%
|
6.64%
|
4.99%
|
19%
|
ROA (Net income/ Total Assets)
|
-0.14%
|
1.51%
|
1.97%
|
2.54%
|
1.96%
|
11.7%
|
Assets
1 |
-16,469
|
3,814
|
2,720
|
2,801
|
2,870
|
2,042
|
Book Value Per Share
2 |
139.0
|
144.0
|
147.0
|
155.0
|
162.0
|
192.0
|
Cash Flow per Share
2 |
1.340
|
4.420
|
6.160
|
4.210
|
2.990
|
7.550
|
Capex
1 |
5.9
|
30.7
|
55
|
17.8
|
55.1
|
243
|
Capex / Sales
|
0.6%
|
2.74%
|
4.17%
|
1.24%
|
3.45%
|
11.84%
|
Announcement Date
|
29/08/18
|
22/08/19
|
28/08/20
|
30/08/21
|
26/08/22
|
31/08/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.99% | 32.58M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|